Knockout of the peroxiredoxin 5 homologue PFAOP does not affect the artemisinin susceptibility of Plasmodium falciparum
Abstract Artemisinins are the current mainstay of malaria chemotherapy. Their exact mode of action is an ongoing matter of debate, and several factors have recently been reported to affect an early stage of artemisinin resistance of the most important human malaria parasite Plasmodium falciparum. He...
Main Authors: | Carine F. Djuika, Verena Staudacher, Cecilia P. Sanchez, Michael Lanzer, Marcel Deponte |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-04277-5 |
Similar Items
-
Characterization of the glutathione-dependent reduction of the peroxiredoxin 5 homolog PfAOP from Plasmodium falciparum
by: Deponte, M., et al.
Published: (2022) -
Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
by: Maëlle Duffey, et al.
Published: (2018-03-01) -
Prokaryotic ancestry and gene fusion of a dual localized peroxiredoxin in malaria parasites
by: Carine F. Djuika, et al.
Published: (2015-01-01) -
Characterisation of resistance to artemisinin in Plasmodium falciparum
by: Duraisingh, Manoj Theodore
Published: (1999) -
The characterization of adaptor protein homologues in Plasmodium falciparum
by: Meredith, Sandra Allison
Published: (2014)